Linked Life Data

7450906

Source:http://linkedlifedata.com/resource/pubmed/id/7450906

Statements in which the resource exists as a subject.
PredicateObject
rdf:type
lifeskim:mentions
pubmed:issue
1
pubmed:dateCreated
1981-3-17
pubmed:abstractText
Our previous findings that antigens, such as ovalbumin (OA) and the extract of ragweed pollen (RAG), could be rendered nonantigenic, nonallergenic and tolerogenic by conjugation with polyethylene glycol (PEG) have been extended in the present study to the synthesis of conjugates of a variety of antigens with monofunctional monomethoxy-PEGs (mPEGS) of different molecular weights by the use of the mixed anhydride method. Thus, mPEGs with molecular weights of 2,000, 5,000, 10,000 and 20,000 were coupled to proteins such as dog serum albumin (DA), bovine pancreatic ribonuclease, OA and the constituents of pollen, helminth and bacterial allergens (RAG, Timothy grass pollen, Ascaris suum and Micropolyspora faeni). All these mPEG conjugates depressed markedly the ongoing IgE antibody formation in sensitized animals, in spite of additional injections of the sensitizing dose of the appropriate antigen. Moreover, the allergenicity of the proteins was either totally abolished or markedly reduced after coupling to mPEGs. Conjugates of DA and OA of varying degree of substitution (i.e. number of mPEG molecules attached per protein molecule) were prepared with mPEGs of different molecular weights and their immunological properties were assessed. It appears that, for a series of tolerogenic conjugates of the same antigen, there exists some inverse relationship between the degree of substitution and the molecular weight of mPEG, i.e. a high level of tolerogenicity with a concomitant reduction or total loss of allergenicity was achieved with a lower degree of substitution utilizing mPEGs of increasing molecular weights. On the basis of these results, it is concluded that a variety of allergens may be converted by conjugation with mPEGs to tolerogenic products with a potential for use in the therapy of patients allergic to a wide spectrum of common allergens.
pubmed:grant
pubmed:language
eng
pubmed:journal
pubmed:citationSubset
IM
pubmed:chemical
pubmed:status
MEDLINE
pubmed:issn
0020-5915
pubmed:author
pubmed:issnType
Print
pubmed:volume
64
pubmed:owner
NLM
pubmed:authorsComplete
Y
pubmed:pagination
84-99
pubmed:dateRevised
2007-11-14
pubmed:meshHeading
pubmed-meshheading:7450906-Albumins, pubmed-meshheading:7450906-Allergens, pubmed-meshheading:7450906-Anhydrides, pubmed-meshheading:7450906-Animals, pubmed-meshheading:7450906-Antibody Formation, pubmed-meshheading:7450906-Ascaris, pubmed-meshheading:7450906-Dogs, pubmed-meshheading:7450906-Immune Tolerance, pubmed-meshheading:7450906-Immunosuppression, pubmed-meshheading:7450906-Mice, pubmed-meshheading:7450906-Mice, Inbred C57BL, pubmed-meshheading:7450906-Mice, Inbred DBA, pubmed-meshheading:7450906-Micromonosporaceae, pubmed-meshheading:7450906-Molecular Weight, pubmed-meshheading:7450906-Ovalbumin, pubmed-meshheading:7450906-Pollen, pubmed-meshheading:7450906-Polyethylene Glycols, pubmed-meshheading:7450906-Rats, pubmed-meshheading:7450906-Reagins, pubmed-meshheading:7450906-Ribonucleases
pubmed:year
1981
pubmed:articleTitle
Suppression of reaginic antibodies with modified allergens. III. Preparation of tolerogenic conjugates of common allergens with monomethoxypolyethylene glycols of different molecular weights by the mixed anhydride method.
pubmed:publicationType
Journal Article, Research Support, U.S. Gov't, P.H.S., Research Support, Non-U.S. Gov't